Wiggans Thomas G
- SEC CIK
- 0001208907
No open-market purchases or sales filed in the past year.
Current role at each company
- JSPR Jasper Therapeutics, Inc.Directoras of Aug 4, 2026
- PCRX Pacira BioSciences, Inc.Directoras of Jun 12, 2026
- ANNX Annexon, Inc.Directoras of Jun 9, 2025
- CBAY CymaBay Therapeutics, Inc.Directoras of Mar 22, 2024
- PRDS Pardes Biosciences, Inc.Chief Executive Officeras of Aug 31, 2023
Show 1 more company
- FMTX Forma Therapeutics Holdings, Inc.Directoras of Oct 14, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Wiggans Thomas G as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
JSPR Jasper Therapeutics, Inc.
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 20, 2023 (view filing) | Nov 16-20 | 4 days | Wiggans Thomas GDirector | PPurchaseVoting Common Stock | +30.0K | $0.61 | +$18.3K | New position30.0K after | 3 lots |
| Nov 22, 2023 (view filing) | Nov 21 | 1 day | Wiggans Thomas GDirector | PPurchaseVoting Common Stock | +10.0K | $0.64 | +$6.40K | +33.3%40.0K after | |
| Nov 30, 2023 (view filing) | Nov 28 | 2 days | Wiggans Thomas GDirector | PPurchaseVoting Common Stock | +10.0K | $0.65 | +$6.50K | +25.0%50.0K after | |
| Sep 24, 2025 (view filing) | Sep 22 | 2 days | Wiggans Thomas GDirector | PPurchaseVoting Common Stock | +41.0K | $2.43 | +$99.6K | New position41.0K after | |
| Sep 24, 2025 (view filing) | Sep 22 | 2 days | Wiggans Thomas GDirector | PPurchaseVoting Common Stock | +41.0K | – | – | –41.0K after | DerivativeDuplicate filing |
PRDS Pardes Biosciences, Inc.
Chief Executive Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2022 (view filing) | Dec 1-2 | 4 days | Wiggans Thomas GChief Executive Officer | PPurchase | +37.5K | $1.05 | +$39.4K | New position37.5K after | 2 lots |
| Dec 7, 2022 (view filing) | Dec 5 | 2 days | Wiggans Thomas GChief Executive Officer | PPurchase | +12.5K | $1.09 | +$13.6K | +33.3%50.0K after |